You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Clonality

Showing 1 - 25 of 150
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Cancer Of Prostate Trial run by the National Cancer Institute (NCI) (M9241, Stereotactic Body Radiation Therapy (SBRT))

Recruiting
  • Cancer Of Prostate
  • M9241
  • Stereotactic Body Radiation Therapy (SBRT)
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Feb 2, 2023

Thrombotic Complications (CLOJAK)

Not yet recruiting
  • Myeloproliferative Neoplasm
  • Blood sampling
  • Angers, France
  • +10 more
Apr 20, 2023

Samples and Clinical Data From Patients With Amyloid Diseases

Recruiting
  • Multiple Myeloma
  • clonality analysis
  • +6 more
  • Boston, Massachusetts
    Boston University Cancer Research Center
Jan 28, 2023

Myeloproliferative Tumor, Optical Genome Mapping, Cytogenetics Trial in Amiens (Blood sample)

Recruiting
  • Myeloproliferative Neoplasm
  • +4 more
  • Blood sample
  • Amiens, Picardie, France
    Centre Hospitalier Universitaire d'Amiens
Jan 27, 2023

Minimal Residual Disease in Peripheral T-cell Lymphoma

Active, not recruiting
  • Peripheral T Cell Lymphoma
  • Tumor biopsy
  • +2 more
  • Boston, Massachusetts
  • +2 more
Dec 19, 2022

Pathogenic Variants in Homologous Recombination Repair Genes in

Completed
  • Epithelial Ovarian Cancer
  • Tumor molecular profiling
  • (no location specified)
Jan 18, 2021

T-Cell Repertoire Sequencing: Assessing Pembrolizumab Efficacy

Not yet recruiting
  • Non-small Cell Lung Cancer Metastatic
    • (no location specified)
    Sep 13, 2023

    Hepatocellular Carcinoma, Hepatitis b Virus, Radiotherapy Trial

    Not yet recruiting
    • Hepatocellular Carcinoma
    • +3 more
      • (no location specified)
      Feb 21, 2023

      Accuracy Evaluation of the IdentiClone Dx IGH Assay

      Not yet recruiting
      • B-Cell Lymphoproliferative Disorder
      • IdentiClone Dx IGH (IC IGH Dx) Assay
      • San Diego, California
      • +2 more
      Oct 30, 2023

      Parathyroid Tumor Clonal Status

      Active, not recruiting
      • Parathyroid Tumor
      • Primary Hyperparathyroidism
        • Birmingham, Alabama
        • +2 more
        Aug 11, 2023

        Molecular Diagnostic for VitreoRetinal Lymphoma

        Not yet recruiting
        • Vitreoretinal Lymphoma
          • (no location specified)
          Apr 21, 2023

          Cell-free DNA From Junction of Hepatitis B Virus Integration in

          Active, not recruiting
          • Hepatocellular Carcinoma
            • Taipei, Taiwan
              National Taiwan University Hospital
            Apr 10, 2023

            The Role of B7-H4 in Tumor Vaccine

            Recruiting
            • Glioma
            • tumor vaccine
            • Shanghai, Shanghai, China
              Di Chen
            Nov 26, 2023

            TINO: T Cells in the Nose of Older Adults

            Recruiting
            • Respiratory Tract Infections
            • Aging
              • Leiden, Zuid Holland, Netherlands
                Leiden University Medical Center
              Sep 8, 2023

              Tumor Vaccine Benefit for Gliomas

              Recruiting
              • Glioma
              • DC vaccine
              • Shanghai, China
                Huashan Hospital，Fudan University
              Sep 12, 2023

              Tumor Vaccines for Solid Tumors

              Recruiting
              • Glioma
              • Solid Tumor
              • tumor vaccine
              • +3 more
              • Shanghai, Shanghai, China
                Huashan Hospital, Fudan University
              Oct 22, 2023

              Endometrial Cancer, Uterine Cancer Trial in Chapel Hill (Pembrolizumab, Hysterectomy)

              Recruiting
              • Endometrial Cancer
              • Uterine Cancer
              • Chapel Hill, North Carolina
                Lineberger Comprehensive Cancer Center
              Sep 27, 2022

              Glioblastoma Multiforme Trial in Los Angeles (drug, radiation, procedure)

              Recruiting
              • Glioblastoma Multiforme
              • Los Angeles, California
                Cedars-Sinai Medical Center
              Feb 24, 2022

              Clinical Stage III Cutaneous Melanoma AJCC v8, Pathologic Stage III Cutaneous Melanoma AJCC v8, Pathologic Stage IIIA Cutaneous

              Recruiting
              • Clinical Stage III Cutaneous Melanoma AJCC v8
              • +5 more
              • Jacksonville, Florida
              • +2 more
              Oct 21, 2022

              Relapsed or Refractory CD19+ B-cell Lymphoma, Relapsed or Refractory Chronic Lymphocytic Leukemia, Relapsed or Refractory Small

              Recruiting
              • Relapsed or Refractory CD19+ B-cell Lymphoma
              • +2 more
              • TBI-2001
              • +2 more
              • Toronto, Ontario, Canada
                Princess Margaret Cancer Centre
              Jul 26, 2023

              Acute Adult T-Cell Leukemia/Lymphoma, Adult T-Cell Leukemia/Lymphoma, Chronic Adult T-Cell Leukemia/Lymphoma Trial in United

              Recruiting
              • Acute Adult T-Cell Leukemia/Lymphoma
              • +3 more
              • Atlanta, Georgia
              • +13 more
              Jan 26, 2023

              Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Secondary Acute Myeloid Leukemia

              Recruiting
              • Acute Myeloid Leukemia
              • +3 more
              • Birmingham, Alabama
              • +8 more
              Jan 24, 2023

              Advanced Clear Cell Renal Cell Carcinoma, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer Trial in Seattle (Aldesleukin,

              Recruiting
              • Advanced Clear Cell Renal Cell Carcinoma
              • +3 more
              • Aldesleukin
              • Pembrolizumab
              • Seattle, Washington
                Fred Hutch/University of Washington Cancer Consortium
              Oct 5, 2022

              Lymphoma, Primary Effusion Trial run by the National Cancer Institute (NCI) (Daratumumab SC)

              Not yet recruiting
              • Lymphoma, Primary Effusion
              • Daratumumab SC
              • Bethesda, Maryland
                National Institutes of Health Clinical Center
              Jun 23, 2023

              TIA, Carotid Artery Plaque, Carotid Atherosclerosis Trial in Cambridge (Interleukin-2 [IL-2], Standard care - Carotid

              Not yet recruiting
              • TIA
              • +2 more
              • Interleukin-2 [IL-2]
              • Standard care - Carotid Endarterectomy
              • Cambridge, Cambridgeshire, United Kingdom
                Addenbrookes Hospital
              Aug 2, 2023